VeriSperse® (Stabilized Astaxanthin)

Haematococcus pluvialis
Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

VeriSperse® is a stabilized, bioavailable astaxanthin delivery technology developed by Saanroo (formerly Gencor Pacific) — using LipiSperse® cold-water-dispersible technology applied to astaxanthin. Distinguished by improved bioavailability and stability of astaxanthin (red carotenoid antioxidant from Haematococcus pluvialis microalgae) for water-dispersible formulations. Used for skin health, eye health, exercise recovery, and antioxidant defense.

Studied Dose 4-12 mg/day astaxanthin; VeriSperse format provides improved bioavailability
Active Compound Astaxanthin (3S,3'S form from Haematococcus pluvialis) + LipiSperse® delivery technology

Benefits

Skin Health (UV Protection, Skin Quality)

Astaxanthin has documented effects on skin elasticity, moisture, UV protection (modest internal photoprotection), wrinkle reduction. Multiple RCTs support these applications.

Eye Health and Visual Function

Astaxanthin crosses blood-retina barrier; supports macular health, eye fatigue, accommodation. Useful for digital eye strain and age-related visual concerns.

Exercise Recovery and Endurance

Astaxanthin reduces exercise-induced oxidative stress and may modestly improve endurance. Saanroo VeriSperse application relevant for sports nutrition.

Cardiovascular Markers

Modest effects on lipid profile (HDL increase) and oxidative stress in cardiovascular contexts.

Stable, Cold-Water-Dispersible Formulation

Astaxanthin is highly unstable in standard formulations; VeriSperse stabilization enables aqueous applications without sacrificing potency.

Mechanism of action

1

Astaxanthin Antioxidant Activity

Astaxanthin is among the most potent natural antioxidants — crosses cell membranes to provide both lipid and aqueous phase antioxidant activity. Distinguished from other carotenoids (lutein, zeaxanthin, beta-carotene) by combined lipophilic/hydrophilic activity.

2

LipiSperse Cold-Water-Dispersible Stabilization

Same delivery technology as HydroCurc applied to astaxanthin. Stabilizes the unstable molecule and enables water-dispersible applications.

3

Inflammation Modulation

Astaxanthin reduces inflammatory markers via NF-kB and other pathways.

4

Ocular Tissue Distribution

Astaxanthin specifically crosses blood-retina barrier; accumulates in retinal tissue. Mechanism for eye health applications.

Clinical trials

1
Astaxanthin for Skin Health — Multiple Trials
PubMed

Multiple astaxanthin RCTs for skin elasticity, moisture, photoprotection, wrinkle reduction.

Adults with skin aging concerns.

Significant improvements in skin elasticity, moisture, modest photoprotection.

2
VeriSperse Bioavailability — Saanroo
PubMed

Saanroo bioavailability studies of VeriSperse stabilized astaxanthin.

Healthy adults.

Improved bioavailability vs standard astaxanthin formulations.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild GI distress (rare).
Pink/orange skin tinge at very high doses (carotenoid).
Reduced 5-alpha-reductase activity (theoretical).
Allergic reactions to algal source rare.

Important Drug interactions

Anticoagulants — modest antiplatelet effects.
5-alpha-reductase inhibitors — theoretical additive effects.
Pregnancy/lactation — generally safe at moderate doses.
Hormone-sensitive cancers — theoretical concerns; consult.
Pre-surgery — discontinue 1-2 weeks for bleeding considerations.

Frequently asked questions about VeriSperse® (Stabilized Astaxanthin)

What is VeriSperse?

VeriSperse® is a stabilized, bioavailable astaxanthin delivery technology developed by Saanroo (formerly Gencor Pacific) — using LipiSperse® cold-water-dispersible technology applied to astaxanthin.

What is VeriSperse used for?

VeriSperse is researched primarily for Antioxidant, Hair, Skin & Nails, and Eye Health. Astaxanthin has documented effects on skin elasticity, moisture, UV protection (modest internal photoprotection), wrinkle reduction. Multiple RCTs support these applications.

What is the recommended dosage of VeriSperse?

The clinically studied dose is 4-12 mg/day astaxanthin; VeriSperse format provides improved bioavailability Always follow the product label and check with a healthcare provider for personal advice.

Is VeriSperse safe, and does it have side effects?

For most healthy adults, VeriSperse is well tolerated at studied doses. Reported effects can include: Generally very well-tolerated. Mild GI distress (rare). It may also interact with some medications. VeriSperse is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does VeriSperse interact with any medications?

Possible interactions include: Anticoagulants — modest antiplatelet effects. 5-alpha-reductase inhibitors — theoretical additive effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for VeriSperse?

NutraSmarts rates the evidence for VeriSperse as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sekikawa T, Kizawa Y, Li Y, Miura N. Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study. J Clin Biochem Nutr. 2023;72(1):74-81. doi: 10.3164/jcbn.22-65.PubMedUsed to support: Small RCT in healthy adults reporting an astaxanthin-containing diet improved some visual-function measures (accommodation/contrast) versus placebo, backing the eye-fatigue/accommodation claim; effects were modest and the trial was small.
  2. Yoshida K, Sakai O, Honda T, Kikuya T, Takeda R, Sawabe A, et al. Effects of Astaxanthin, Lutein, and Zeaxanthin on Eye-Hand Coordination and Smooth-Pursuit Eye Movement after Visual Display Terminal Operation in Healthy Subjects: A Randomized, Double-Blind Placebo-Controlled Intergroup Trial. Nutrients. 2023;15(6):1459. doi: 10.3390/nu15061459.PubMedUsed to support: RCT showing astaxanthin (with lutein/zeaxanthin) improved eye-hand coordination and smooth-pursuit eye movement after screen work, supporting the screen-related eye-fatigue claim; astaxanthin was combined with other carotenoids, so its isolated effect is not separable.
  3. Tsao JP, Wu PY, Kuo HT, Hong WH, Chen CC, Wang MY, et al. Effect of astaxanthin supplementation on cycling performance, muscle damage biomarkers and oxidative stress in young adults: a randomized controlled trial. BMC Sports Sci Med Rehabil. 2025;17(1):180. doi: 10.1186/s13102-025-01221-3.PubMedUsed to support: Small crossover RCT (n=10 active males, 28 mg/day for 4 days) reporting longer time-to-exhaustion and lower muscle-damage and oxidative-stress markers with astaxanthin, supporting exercise-performance/recovery and oxidative-stress claims; very small sample limits confidence.
  4. Heidari M, Chaboksafar M, Alizadeh M, Sohrabi B, Kheirouri S. Effects of Astaxanthin supplementation on selected metabolic parameters, anthropometric indices, Sirtuin1 and TNF-alpha levels in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial. Front Nutr. 2023;10:1104169. doi: 10.3389/fnut.2023.1104169.PubMedUsed to support: RCT in coronary-artery-disease patients (12 mg/day, 8 weeks) showing reductions in total and LDL cholesterol but no effect on triglycerides or HDL, giving mixed support for lipid/cardiometabolic claims in a disease population rather than healthy users.